Stoke Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing RNA-based medicines to treat severe genetic diseases. Its lead product candidate, zorevunersen (STK-001), is being developed to treat Dravet syndrome by targeting the underlying genetic cause to reduce seizures and potentially improve behavior and cognition. The company has a collaboration agreement with Biogen International GmbH.
expected 2026-12-25
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-16 | 2025-12-31 | 0001193125-26-108362 | EDGAR | 93K words |
| 2025-03-18 | 2024-12-31 | 0000950170-25-041170 | EDGAR | 91K words |
| 2024-03-25 | 2023-12-31 | 0000950170-24-035912 | EDGAR | 89K words |
| 2023-03-06 | 2022-12-31 | 0001564590-23-003175 | EDGAR | 88K words |
| 2022-03-10 | 2021-12-31 | 0001564590-22-009634 | EDGAR | — |
| 2021-03-09 | 2020-12-31 | 0001564590-21-011760 | EDGAR | — |
| 2020-03-23 | 2019-12-31 | 0001564590-20-012202 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-03 | 2026-06-30 | 0001193125-26-330557 | EDGAR | 58K words |
| 2025-11-04 | 2025-09-30 | 0001193125-25-264720 | EDGAR | 61K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-107332 | EDGAR | 60K words |
| 2025-05-13 | 2025-03-31 | 0000950170-25-070296 | EDGAR | 57K words |
| 2024-11-05 | 2024-09-30 | 0000950170-24-121445 | EDGAR | 55K words |
| 2024-08-07 | 2024-06-30 | 0000950170-24-092738 | EDGAR | 54K words |
| 2024-05-06 | 2024-03-31 | 0000950170-24-053535 | EDGAR | 53K words |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060224 | EDGAR | 55K words |
| 2023-08-07 | 2023-06-30 | 0000950170-23-039050 | EDGAR | 56K words |
| 2023-05-04 | 2023-03-31 | 0000950170-23-017839 | EDGAR | 54K words |
| 2022-11-14 | 2022-09-30 | 0001564590-22-037497 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0001564590-22-028440 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-25 | 0001193125-26-402820 | EDGAR | 1K words |
| 2026-08-03 | 0001193125-26-330804 | EDGAR | 1K words |
| 2026-08-03 | 0001193125-26-330537 | EDGAR | 5K words |
| 2026-03-27 | 0001193125-26-129168 | EDGAR | 1K words |
| 2026-03-03 | 0001193125-26-088205 | EDGAR | 1K words |
| 2026-01-26 | 0001193125-26-022569 | EDGAR | 1K words |
| 2026-01-12 | 0001193125-26-009781 | EDGAR | 2K words |
| 2025-12-05 | 0001193125-25-308781 | EDGAR | 3K words |
| 2025-11-04 | 0001193125-25-264644 | EDGAR | 4K words |
| 2025-10-06 | 0001193125-25-230925 | EDGAR | 5K words |
128 total filings indexed. 99 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001623526 |
| Ticker | STOK |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.stoketherapeutics.com |
| Listed | 2019-06-19 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/STOK (~200 tokens, structured JSON with cryptographic provenance)